Pfizer applies to FDA for emergency approval of its vaccine for children
Pfizer Pharmaceutical and its partner company BioNTech have asked U.S. regulators to approve emergency use of their COVID-19 vaccine for children aged 5 to 11. Pfizer made the announcement in a recent tweet. Pfizer made the application to the U.S. Food and Drug Administration…